Preliminary results from UAB’s CBD oil studies show benefit in seizure control in some patients.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
More evidence that generic medications are as effective as brand name drugs.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
The Alzheimer’s plaques that accumulate around brain cells also congregate along the walls of blood vessels, according to UAB research, and that may contribute to cognitive issues.
Engineers, physicians, computer scientists and statisticians will collaborate to research and apply big data in the health care, industrial and smart cities fields.
A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
Many UAB physicians from a variety of specialties appear on the prestigious Newsweek Top Cancer Doctors 2015 list.
The Hugh Kaul Personalized Medicine Institute recently awarded two collaborative pilot implementation projects to advance precision medicine at UAB.
The award, considered the ANA’s highest and most prestigious, recognizes early- to mid-career neurologists and neuroscientists who have made outstanding basic and clinical scientific advances